Risk factor
Strong trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Target Price
The average target price of 300142.SZ is 8.0 and suggests 33% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to
Buy
Sell